Your browser doesn't support javascript.
loading
Exploiting the metabolic energy demands of drug efflux pumps provides a strategy to overcome multidrug resistance in cancer.
Gao, Xuexin; Aguanno, Doriane; Board, Mary; Callaghan, Richard.
Affiliation
  • Gao X; Human Disease and Membrane Transport Laboratory, Division of Biomedical Science & Biochemistry, Research School of Biology and Medical School, The Australian National University, Canberra 2601, Australia.
  • Aguanno D; Human Disease and Membrane Transport Laboratory, Division of Biomedical Science & Biochemistry, Research School of Biology and Medical School, The Australian National University, Canberra 2601, Australia.
  • Board M; St. Hilda's College, University of Oxford, Oxford OX4 1DY, UK.
  • Callaghan R; Human Disease and Membrane Transport Laboratory, Division of Biomedical Science & Biochemistry, Research School of Biology and Medical School, The Australian National University, Canberra 2601, Australia. Electronic address: richard.callaghan@anu.edu.au.
Biochim Biophys Acta Gen Subj ; 1865(8): 129915, 2021 08.
Article in En | MEDLINE | ID: mdl-33965440

Full text: 1 Database: MEDLINE Main subject: Oxidative Phosphorylation / Breast Neoplasms / Adenosine Triphosphate / Drug Resistance, Multiple / Drug Resistance, Neoplasm / Antineoplastic Agents Limits: Female / Humans Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Oxidative Phosphorylation / Breast Neoplasms / Adenosine Triphosphate / Drug Resistance, Multiple / Drug Resistance, Neoplasm / Antineoplastic Agents Limits: Female / Humans Language: En Year: 2021 Type: Article